Drug Compounding
FDA Scrutinizes Telehealth Firms Like Hims for GLP-1 Drug Advertising Practices
FDA; Hims; telehealth; GLP-1; advertising; weight-loss drugs; compound drugs; Super Bowl ad; misleading claims
Actionable Insights Powered by AI
FDA; Hims; telehealth; GLP-1; advertising; weight-loss drugs; compound drugs; Super Bowl ad; misleading claims